JP2008540453A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540453A5 JP2008540453A5 JP2008510281A JP2008510281A JP2008540453A5 JP 2008540453 A5 JP2008540453 A5 JP 2008540453A5 JP 2008510281 A JP2008510281 A JP 2008510281A JP 2008510281 A JP2008510281 A JP 2008510281A JP 2008540453 A5 JP2008540453 A5 JP 2008540453A5
- Authority
- JP
- Japan
- Prior art keywords
- candida
- composition
- family member
- als protein
- protein family
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 claims 15
- 108090000623 proteins and genes Proteins 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 14
- 239000012634 fragment Substances 0.000 claims 10
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 7
- 230000002163 immunogen Effects 0.000 claims 5
- 229960005486 vaccine Drugs 0.000 claims 5
- 241000222173 Candida parapsilosis Species 0.000 claims 4
- 229940055022 candida parapsilosis Drugs 0.000 claims 4
- 241000222122 Candida albicans Species 0.000 claims 3
- 241000222178 Candida tropicalis Species 0.000 claims 3
- 241000222126 [Candida] glabrata Species 0.000 claims 3
- 229940095731 candida albicans Drugs 0.000 claims 3
- 208000032343 candida glabrata infection Diseases 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 230000021164 cell adhesion Effects 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 210000004897 n-terminal region Anatomy 0.000 claims 3
- 206010041925 Staphylococcal infections Diseases 0.000 claims 2
- 206010042938 Systemic candida Diseases 0.000 claims 2
- 201000003984 candidiasis Diseases 0.000 claims 2
- 208000019164 disseminated candidiasis Diseases 0.000 claims 2
- 210000002889 endothelial cell Anatomy 0.000 claims 2
- 210000002919 epithelial cell Anatomy 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 238000002649 immunization Methods 0.000 claims 2
- 208000015339 staphylococcus aureus infection Diseases 0.000 claims 2
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 108010085895 Laminin Proteins 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 230000009545 invasion Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/123,873 US20060083750A1 (en) | 1999-11-19 | 2005-05-05 | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| PCT/US2006/017482 WO2006121895A2 (en) | 2005-05-05 | 2006-05-04 | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008540453A JP2008540453A (ja) | 2008-11-20 |
| JP2008540453A5 true JP2008540453A5 (https=) | 2009-05-14 |
Family
ID=37397150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008510281A Pending JP2008540453A (ja) | 2005-05-05 | 2006-05-04 | 播種性カンジダ症および他の感染性因子に対してワクチン接種するための薬学的組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060083750A1 (https=) |
| EP (1) | EP1883421A4 (https=) |
| JP (1) | JP2008540453A (https=) |
| AU (1) | AU2006244401B2 (https=) |
| CA (1) | CA2607176A1 (https=) |
| WO (1) | WO2006121895A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) * | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| WO2011003085A1 (en) * | 2009-07-03 | 2011-01-06 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Hyr1 as a target for active and passive immunization against candida |
| JP2014515757A (ja) * | 2011-04-21 | 2014-07-03 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ | 真菌感染症のペプチド及び結合型ワクチン |
| GEP201706766B (en) * | 2011-07-22 | 2017-10-25 | Los Angeles Biomedical Res Center | Methods and compositions for vaccinating against staphylococcus aureus |
| US10130691B2 (en) | 2013-03-15 | 2018-11-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
| EP3426287A4 (en) | 2016-03-09 | 2020-03-11 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622939A (en) * | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
| US5668263A (en) * | 1994-12-16 | 1997-09-16 | Smithkline Beecham Corporation | Conserved yeast nucleic acid sequences |
| US5858378A (en) * | 1996-05-02 | 1999-01-12 | Galagen, Inc. | Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen |
| US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| US7067138B1 (en) * | 1999-11-19 | 2006-06-27 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| US8541008B2 (en) * | 1999-11-19 | 2013-09-24 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against candidiasis |
| US20070077256A1 (en) * | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| US6734344B2 (en) * | 1999-12-10 | 2004-05-11 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agrifood | Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1 |
| US7241613B1 (en) * | 2002-06-05 | 2007-07-10 | Oscient Pharmaceuticals Corporation | Identification of Candida cell surface proteins and their uses |
| BRPI0711572A2 (pt) * | 2006-04-17 | 2011-11-16 | Schering Plough Ltd | organismos recombinantes atenuados de clostridium e vacinas |
-
2005
- 2005-05-05 US US11/123,873 patent/US20060083750A1/en not_active Abandoned
-
2006
- 2006-05-04 WO PCT/US2006/017482 patent/WO2006121895A2/en not_active Ceased
- 2006-05-04 JP JP2008510281A patent/JP2008540453A/ja active Pending
- 2006-05-04 AU AU2006244401A patent/AU2006244401B2/en not_active Ceased
- 2006-05-04 CA CA002607176A patent/CA2607176A1/en not_active Abandoned
- 2006-05-04 EP EP06752341A patent/EP1883421A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009524601A5 (https=) | ||
| Luo et al. | Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans | |
| CY1113693T1 (el) | Φαρμακευτικες συνθεσεις και μεθοδοι για τον εμβολιασμο κατα της διαχυτης καντιντιασης και αλλων μολυσματικων παραγοντων | |
| US8785375B2 (en) | Cyclic antimicrobial peptides for treating bacterial infections | |
| WO2007022425A3 (en) | Influenza recombinant subunit vaccine | |
| EP3064220A3 (en) | Compositions and methods for the treatment of infections and tumors | |
| JP2009544722A5 (https=) | ||
| IL274109B1 (en) | Leukocyte-killers of Staphylococcus aureus, pharmaceutical preparations, and their use | |
| JP2010222367A5 (https=) | ||
| JP2009526751A5 (https=) | ||
| US9518093B2 (en) | Topical formulation of arginine-rich cyclic antimicrobial peptides | |
| WO2007146024A3 (en) | Cytomegalovirus surface protein complex for use in vaccines and as a drug target | |
| JP2013542919A5 (https=) | ||
| JP2012532114A5 (https=) | ||
| JP2011503065A5 (https=) | ||
| JP2008540453A5 (https=) | ||
| JP2012521366A5 (https=) | ||
| DK1677777T3 (da) | Pellets indeholdende venlafaxin-hydrochlorid | |
| JP2014528715A5 (https=) | ||
| WO2009005798A3 (en) | Antifungal formulation and method of preparation | |
| JP2012520665A5 (https=) | ||
| WO2007018463A3 (en) | Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system | |
| Xu et al. | Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs | |
| WO2009077744A3 (en) | Vaccines for brucellosis | |
| WO2006121895A3 (en) | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |